CD24 Protein (AA 27-54) (Fc Tag)

Produktnummer ABIN7274098

Produktdetails

Target: CD24 (CD24 Molecule (CD24))

Protein-Typ: Recombinant

Proteineigenschaft: AA 27-54

Spezies: Cynomolgus

Quelle: HEK-293 Cells

Aufreinigungstag / Konjugat: Dieses CD24 Protein ist gelabelt mit Fc Tag.

Verwendungszweck: Cynomolgus CD24 Protein

Sequenz: Thr27-Lys54

Produktmerkmale: Recombinant Cynomolgus CD24 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Thr27-Lys54.

Reinheit: > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC

Sterilität: 0.22 μm filtered

Endotoxin-Niveau: Less than 1EU per μg by the LAL method.

Anwendungsinformationen

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

Buffer: Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3-6 months after reconstitution.,2-8°C for 2-7 days after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Haltbarkeit: 12 months

Antigendetails

Target: CD24 (CD24 Molecule (CD24))

Andere Bezeichnung: CD24 (CD24 Produkte)

Synonyme: CD24A Protein, Cd24a Protein, CD24 molecule Protein, CD24 Protein, Cd24 Protein

Hintergrund: CD24 is a sialoglycoprotein expressed at the surface of most B lymphocytes and differentiating neuroblasts. It is also expressed on neutrophils and neutrophil precursors from the myelocyte stage onwards. The potential for targeting CD24 in cancer therapy seems promising, as CD24 is overexpressed in many human cancers.

Molekulargewicht: 30.2 kDa. Due to glycosylation, the protein migrates to 45-60 kDa based on Tris-Bis PAGE result.

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Activated T Cell Proliferation